Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)
Identifieur interne : 000791 ( Pmc/Corpus ); précédent : 000790; suivant : 000792Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)
Auteurs : Kf To ; Anthony Wi LoSource :
- The Journal of Pathology [ 0022-3417 ] ; 2004.
Abstract
Severe acute respiratory syndrome (SARS) is an emerging infectious disease associated with a new coronavirus, SARS‐CoV. Pulmonary involvement is the dominant clinical feature but extra‐pulmonary manifestations are also common. Factors that account for the wide spectrum of organ system involvement and disease severity are poorly understood and the pathogenesis of SARS‐CoV infection remains unclear. Angiotensin converting enzyme 2 (ACE2) has recently been identified as the functional cellular receptor for SARS‐CoV. Studies of the tissue and cellular distribution of SARS‐CoV, and ACE2 protein expression, reveal new insights into the pathogenesis of this deadly disease. ACE2 is expressed at high level in the primary target cells of SARS‐CoV, namely pneumocytes and surface enterocytes of the small intestine. Despite the fact that SARS‐CoV can infect the lung and intestine, the tissue responses in these two organs are different. All other tissues and cell types expressing ACE2 may be potential targets of SARS‐CoV infection. Remarkably, endothelial cells, which express ACE2 to a high level, have not been shown to be infected by SARS‐CoV. There is also evidence that cell types without detectable ACE2 expression may also be infected by the virus. Furthermore, studies in a new human cell culture model have indicated that the presence of ACE2 alone is not sufficient for maintaining viral infection. Therefore, other virus receptors or co‐receptors may be required in different tissues. Moreover, the interaction between SARS‐CoV and the immunological or lymphoid system remains to be defined. It is clear that we are only at the dawn of our understanding of the pathogenesis of SARS. As our knowledge of the pathogenic mechanisms improves, a more rational approach to therapeutic and vaccine development can be designed in order to combat this new and fatal human disease. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Url:
DOI: 10.1002/path.1597
PubMed: NONE
PubMed Central: 7167902
Links to Exploration step
PMC:7167902Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)</title>
<author><name sortKey="To, Kf" sort="To, Kf" uniqKey="To K" first="Kf" last="To">Kf To</name>
<affiliation><nlm:aff id="af1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lo, Anthony Wi" sort="Lo, Anthony Wi" uniqKey="Lo A" first="Anthony Wi" last="Lo">Anthony Wi Lo</name>
<affiliation><nlm:aff id="af1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7167902</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167902</idno>
<idno type="RBID">PMC:7167902</idno>
<idno type="doi">10.1002/path.1597</idno>
<idno type="pmid">NONE</idno>
<date when="2004">2004</date>
<idno type="wicri:Area/Pmc/Corpus">000791</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000791</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)</title>
<author><name sortKey="To, Kf" sort="To, Kf" uniqKey="To K" first="Kf" last="To">Kf To</name>
<affiliation><nlm:aff id="af1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lo, Anthony Wi" sort="Lo, Anthony Wi" uniqKey="Lo A" first="Anthony Wi" last="Lo">Anthony Wi Lo</name>
<affiliation><nlm:aff id="af1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of Pathology</title>
<idno type="ISSN">0022-3417</idno>
<idno type="eISSN">1096-9896</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Abstract</title>
<p>Severe acute respiratory syndrome (SARS) is an emerging infectious disease associated with a new coronavirus, SARS‐CoV. Pulmonary involvement is the dominant clinical feature but extra‐pulmonary manifestations are also common. Factors that account for the wide spectrum of organ system involvement and disease severity are poorly understood and the pathogenesis of SARS‐CoV infection remains unclear. Angiotensin converting enzyme 2 (ACE2) has recently been identified as the functional cellular receptor for SARS‐CoV. Studies of the tissue and cellular distribution of SARS‐CoV, and ACE2 protein expression, reveal new insights into the pathogenesis of this deadly disease. ACE2 is expressed at high level in the primary target cells of SARS‐CoV, namely pneumocytes and surface enterocytes of the small intestine. Despite the fact that SARS‐CoV can infect the lung and intestine, the tissue responses in these two organs are different. All other tissues and cell types expressing ACE2 may be potential targets of SARS‐CoV infection. Remarkably, endothelial cells, which express ACE2 to a high level, have not been shown to be infected by SARS‐CoV. There is also evidence that cell types without detectable ACE2 expression may also be infected by the virus. Furthermore, studies in a new human cell culture model have indicated that the presence of ACE2 alone is not sufficient for maintaining viral infection. Therefore, other virus receptors or co‐receptors may be required in different tissues. Moreover, the interaction between SARS‐CoV and the immunological or lymphoid system remains to be defined. It is clear that we are only at the dawn of our understanding of the pathogenesis of SARS. As our knowledge of the pathogenic mechanisms improves, a more rational approach to therapeutic and vaccine development can be designed in order to combat this new and fatal human disease. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="article-commentary"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Pathol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Pathol</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1096-9896</journal-id>
<journal-id journal-id-type="publisher-id">PATH</journal-id>
<journal-title-group><journal-title>The Journal of Pathology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3417</issn>
<issn pub-type="epub">1096-9896</issn>
<publisher><publisher-name>John Wiley & Sons, Ltd.</publisher-name>
<publisher-loc>Chichester, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmc">7167902</article-id>
<article-id pub-id-type="doi">10.1002/path.1597</article-id>
<article-id pub-id-type="publisher-id">PATH1597</article-id>
<article-categories><subj-group subj-group-type="overline"><subject>Commentary</subject>
</subj-group>
<subj-group subj-group-type="heading"><subject>Commentaries</subject>
</subj-group>
</article-categories>
<title-group><article-title>Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)</article-title>
<alt-title alt-title-type="right-running-head">Commentary</alt-title>
</title-group>
<contrib-group><contrib id="au1" contrib-type="author" corresp="yes"><name><surname>To</surname>
<given-names>KF</given-names>
</name>
<xref ref-type="aff" rid="af1"><sup>1</sup>
</xref>
<address><email>kfto@cuhk.edu.hk</email>
</address>
</contrib>
<contrib id="au2" contrib-type="author"><name><surname>Lo</surname>
<given-names>Anthony WI</given-names>
</name>
<xref ref-type="aff" rid="af1"><sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="af1"><label><sup>1</sup>
</label>
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China</aff>
<author-notes><corresp id="correspondenceTo"><label>*</label>
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, 30‐32 Ngan Shing Street, Shatin, NT, Hong Kong SAR, China.</corresp>
</author-notes>
<pub-date pub-type="epub"><day>21</day>
<month>6</month>
<year>2004</year>
</pub-date>
<pub-date pub-type="ppub"><month>7</month>
<year>2004</year>
</pub-date>
<volume>203</volume>
<issue>3</issue>
<issue-id pub-id-type="doi">10.1002/path.v203:3</issue-id>
<fpage>740</fpage>
<lpage>743</lpage>
<history><date date-type="received"><day>29</day>
<month>4</month>
<year>2004</year>
</date>
<date date-type="accepted"><day>29</day>
<month>4</month>
<year>2004</year>
</date>
</history>
<permissions><copyright-statement content-type="article-copyright">Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</copyright-statement>
<license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:PATH-203-740.pdf"></self-uri>
<abstract><title>Abstract</title>
<p>Severe acute respiratory syndrome (SARS) is an emerging infectious disease associated with a new coronavirus, SARS‐CoV. Pulmonary involvement is the dominant clinical feature but extra‐pulmonary manifestations are also common. Factors that account for the wide spectrum of organ system involvement and disease severity are poorly understood and the pathogenesis of SARS‐CoV infection remains unclear. Angiotensin converting enzyme 2 (ACE2) has recently been identified as the functional cellular receptor for SARS‐CoV. Studies of the tissue and cellular distribution of SARS‐CoV, and ACE2 protein expression, reveal new insights into the pathogenesis of this deadly disease. ACE2 is expressed at high level in the primary target cells of SARS‐CoV, namely pneumocytes and surface enterocytes of the small intestine. Despite the fact that SARS‐CoV can infect the lung and intestine, the tissue responses in these two organs are different. All other tissues and cell types expressing ACE2 may be potential targets of SARS‐CoV infection. Remarkably, endothelial cells, which express ACE2 to a high level, have not been shown to be infected by SARS‐CoV. There is also evidence that cell types without detectable ACE2 expression may also be infected by the virus. Furthermore, studies in a new human cell culture model have indicated that the presence of ACE2 alone is not sufficient for maintaining viral infection. Therefore, other virus receptors or co‐receptors may be required in different tissues. Moreover, the interaction between SARS‐CoV and the immunological or lymphoid system remains to be defined. It is clear that we are only at the dawn of our understanding of the pathogenesis of SARS. As our knowledge of the pathogenic mechanisms improves, a more rational approach to therapeutic and vaccine development can be designed in order to combat this new and fatal human disease. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</p>
</abstract>
<kwd-group kwd-group-type="author-generated"><kwd id="kwd1">SARS</kwd>
<kwd id="kwd2">coronavirus</kwd>
<kwd id="kwd3">ACE2</kwd>
<kwd id="kwd4">pathogenesis</kwd>
</kwd-group>
<counts><fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<ref-count count="43"></ref-count>
<page-count count="4"></page-count>
</counts>
<custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta><meta-name>cover-date</meta-name>
<meta-value>July 2004</meta-value>
</custom-meta>
<custom-meta><meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body><p>Severe acute respiratory syndrome (SARS) haunted the world from November 2002 to July 2003, affecting more than 8000 people in 28 regions with a mortality of 9.6% <xref rid="bib1" ref-type="ref">1</xref>
. Since then, sporadic mini‐outbreaks have arisen from laboratory and various other sources, resulting in public panic as well as posting continuous reminders to the medical world of this new disease <xref rid="bib2" ref-type="ref">2</xref>
. The SARS epidemic, on the other hand, clearly demonstrated international co‐operation and advances in genomic technology <xref rid="bib3" ref-type="ref">3</xref>
. The causative agent of SARS, a new coronavirus (SARS‐CoV), was quickly identified and the genomes of various isolates were determined <xref rid="bib4" ref-type="ref">4</xref>
, <xref rid="bib5" ref-type="ref">5</xref>
, <xref rid="bib6" ref-type="ref">6</xref>
, <xref rid="bib7" ref-type="ref">7</xref>
. Patients with SARS‐CoV infection have a wide spectrum of disease, varying from a self‐limiting illness to a fatal outcome <xref rid="bib8" ref-type="ref">8</xref>
, <xref rid="bib9" ref-type="ref">9</xref>
. The clinical picture was dominated by respiratory system involvement <xref rid="bib8" ref-type="ref">8</xref>
, <xref rid="bib10" ref-type="ref">10</xref>
but gastrointestinal symptoms were also common <xref rid="bib11" ref-type="ref">11</xref>
, <xref rid="bib12" ref-type="ref">12</xref>
. Raised creatine kinase, an increase in lactate dehydrogenase, and a decrease in absolute lymphocyte count are the most common laboratory findings. The best treatment protocol has not yet been defined, although vaccines are currently being developed in major centres around the world <xref rid="bib13" ref-type="ref">13</xref>
, <xref rid="bib14" ref-type="ref">14</xref>
, <xref rid="bib15" ref-type="ref">15</xref>
, <xref rid="bib16" ref-type="ref">16</xref>
. The factors that account for the wide spectrum of organ system involvement and disease severity are poorly understood. The pathogenesis of SARS‐CoV infection remains uncertain.</p>
<p>As an important step towards better understanding of the pathogenesis, pathologists play a pivotal role in defining the tropism of the SARS‐CoV and the body's responses to viral infection at the cellular and tissue levels. Several studies have attempted to characterize the lung pathology of SARS. Most of these studies analysed fatal cases, representing the more severe end of the clinical spectrum <xref rid="bib8" ref-type="ref">8</xref>
, <xref rid="bib17" ref-type="ref">17</xref>
, <xref rid="bib18" ref-type="ref">18</xref>
, <xref rid="bib19" ref-type="ref">19</xref>
, <xref rid="bib20" ref-type="ref">20</xref>
, <xref rid="bib21" ref-type="ref">21</xref>
, <xref rid="bib22" ref-type="ref">22</xref>
. In the lung, diffuse alveolar damage and syncytial cells are most consistently seen. Using electron microscopy (EM) directly for viral particles, <italic>in situ</italic>
hybridization (ISH) using various regions of the viral genome <xref rid="bib23" ref-type="ref">23</xref>
, <xref rid="bib24" ref-type="ref">24</xref>
, <xref rid="bib25" ref-type="ref">25</xref>
, and immunohistochemical (IHC) studies using antibodies against various viral proteins (Figure <xref rid="fig1" ref-type="fig">1</xref>
A and ref <xref rid="bib26" ref-type="ref">26</xref>
), SARS‐CoV infections have been clearly demonstrated in pneumocytes. This cell type is probably the primary target of SARS‐CoV.</p>
<fig fig-type="Figure" xml:lang="en" id="fig1" orientation="portrait" position="float"><label>Figure 1</label>
<caption><p>Detection of SARS‐CoV membrane (M) protein in tissues from SARS patients by immunohistochemistry (1 : 100) using an anti‐peptide antibody with a previously described routine protocol <xref rid="bib22" ref-type="ref">22</xref>
. Note the cytoplasmic expression of this protein in SARS‐CoV‐infected cells (arrows). (A) Pneumocytes of the lung (original magnification ×400) and (B) surface enterocytes of the small intestine (original magnification ×200). Similar results were obtained using anti‐peptide antibodies against N (nucleocapsid) and S (spike) proteins. These antibodies were generated from rabbits immunized with a KLH‐conjugated synthetic peptide selected from the N‐ or C‐termini of the respective SARS‐CoV proteins. These figures are from autopsy samples, which were used as part of our ongoing project on SARS, approved by the local ethical committee</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="PATH-203-740-g001"></graphic>
</fig>
<p>A substantial number of patients with SARS have diarrhoea <xref rid="bib12" ref-type="ref">12</xref>
, <xref rid="bib27" ref-type="ref">27</xref>
. In the intestine, little pathology is observed at the light microscopy level, either in biopsies taken during early phases <xref rid="bib12" ref-type="ref">12</xref>
or in autopsy specimens <xref rid="bib22" ref-type="ref">22</xref>
, <xref rid="bib25" ref-type="ref">25</xref>
. EM <xref rid="bib12" ref-type="ref">12</xref>
, ISH <xref rid="bib25" ref-type="ref">25</xref>
, and IHC (Figure <xref rid="fig1" ref-type="fig">1</xref>
B), however, revealed the presence of SARS‐CoV in surface enterocytes. The presence of virus in stool <xref rid="bib12" ref-type="ref">12</xref>
, <xref rid="bib28" ref-type="ref">28</xref>
and contamination of sewage were implicated as a possible mechanism of transmission in one major outbreak in Hong Kong <xref rid="bib29" ref-type="ref">29</xref>
.</p>
<p>Such comprehensive evidence for the presence of all three viral components—viral genome, viral proteins, and virus particles—is lacking in other cell types. In one of two papers on SARS published in the June 2004 issue of <italic>The Journal of Pathology</italic>
, Ding <italic>et al</italic>
extended the list of organs harbouring the virus in fatal cases using both IHC with antibodies to the nucleocapsid (N) protein and ISH <xref rid="bib26" ref-type="ref">26</xref>
. Among the various organs in which IHC and ISH are positive for SARS‐CoV, the presence of virus in the sweat glands suggests that SARS may be spread via contact with the skin. Although such a phenomenon has not been demonstrated clinically or epidemiologically, this finding might have major implications in clinical practice, infection control, and waste handling. Similarly, the presence of virus in the distal convoluted tubules of the kidney is consistent with detection of the viral genome in urine and suggests that urine may be an additional source of sewage contamination <xref rid="bib28" ref-type="ref">28</xref>
. However, specific renal tissue damage was not observed, nor was viral tropism in kidney demonstrated in a previous ISH study <xref rid="bib25" ref-type="ref">25</xref>
, and the virus was not explicitly seen by EM <xref rid="bib17" ref-type="ref">17</xref>
, <xref rid="bib18" ref-type="ref">18</xref>
, <xref rid="bib19" ref-type="ref">19</xref>
, <xref rid="bib20" ref-type="ref">20</xref>
, <xref rid="bib21" ref-type="ref">21</xref>
, <xref rid="bib22" ref-type="ref">22</xref>
.</p>
<p>Observations in the liver are also interesting. A high proliferative index has been demonstrated in hepatocytes in some cases <xref rid="bib30" ref-type="ref">30</xref>
. Viral particles are again not detected by EM <xref rid="bib30" ref-type="ref">30</xref>
. In both the liver and the kidney, signals for SARS‐CoV were detected by both IHC and ISH <xref rid="bib26" ref-type="ref">26</xref>
, yet EM failed to reveal recognizable viral particles. If the observations are real, this raises the question of whether the virus exists in a non‐packaged form. The discrepancy between these observations remains unexplained. The presence of viral infection in some endocrine organs such as the adrenals and the pituitary is puzzling. This finding might open up new insights into the pathophysiology of SARS. However, clinical presentations of SARS have not been linked to any particular endocrine disturbance.</p>
<p>The discovery and characterization of cellular receptor of SARS‐CoV might provide important clues to the pathogenesis of this novel virus. Angiotensin converting enzyme 2 (ACE2), a metalloproteinase that has previously attracted attention as a result of its role in the cardiovascular system <xref rid="bib31" ref-type="ref">31</xref>
, was recently identified as the receptor of SARS‐CoV in Vero E6 cells by isolation of the receptor protein through its direct interaction with the Spike (S) proteins of the SARS‐CoV <xref rid="bib32" ref-type="ref">32</xref>
and by expression cloning <xref rid="bib33" ref-type="ref">33</xref>
. Further biochemical analysis pinpointed specific regions of the S1 domain of the S protein of SARS‐CoV that interacted strongly with ACE2 <xref rid="bib34" ref-type="ref">34</xref>
, <xref rid="bib35" ref-type="ref">35</xref>
. These findings will have important bearings on vaccine development. Transfection of ACE2 into NIH 3T3 cells apparently conveyed infectivity to these non‐permissive cells. Syncytium formation in ACE2‐transfected cells has also been reported <xref rid="bib32" ref-type="ref">32</xref>
. In the second paper on SARS published in the June 2004 issue of <italic>The Journal of Pathology</italic>
, Hamming <italic>et al</italic>
provided important information on the tissue and cellular distribution of ACE2 protein <xref rid="bib36" ref-type="ref">36</xref>
. The general pattern of ACE2 expression correlates roughly with the tropism of SARS‐CoV in fatal cases. In particular, ACE2 proteins were seen in the alveolar epithelial cells and surface enterocytes of the small intestine. The physiological role of ACE2 expression in these epithelial cell types is currently unknown. Interesting discrepancies between the tissue distribution of ACE2 and the tropism of SARS‐CoV are, however, immediately apparent. While high levels of ACE2 are seen in endothelial cells, viral infection has not been demonstrated extensively in these cells in any organ, although vasculitis has been reported <xref rid="bib18" ref-type="ref">18</xref>
. Similarly, ACE2 is clearly demonstratable by IHC in glomerular visceral and parietal epithelial cells as well as in the proximal tubules, but SARS‐CoV infection has not been observed in these cell types. In contrast, no ACE2 expression was noted in the different cell types in the liver, including hepatocytes, Kupffer cells, and sinusoidal endothelium.</p>
<p>In the search for cell culture models for SARS‐CoV infection, it has become clear that ACE2, as a receptor of SARS‐CoV, cannot be the only determinant of tissue tropism. Several intestinal cell lines were found to have significant expression of ACE2, but only one human intestinal adenocarcinoma cell line, Lovo, was eventually identified to be permissive for SARS‐CoV infection <xref rid="bib37" ref-type="ref">37</xref>
. In contrast to the infected Vero E6 cell line, Lovo cells showed no cytopathic effect upon infection by SARS‐CoV. Instead, persistent infection was observed. Virus particles, viral genome, and viral proteins were all demonstrated in SARS‐CoV‐infected Lovo cells. This cell culture model appears to recapitulate the natural course of intestinal SARS‐CoV infection. It is apparent that the effect of SARS‐CoV infection is different in different cell types and it is possible that the virus may utilize different receptors, or involve various co‐receptors, in these different cells.</p>
<p>Immunological aspects of the study of pathogenesis cannot be overlooked. Lymphopenia is a characteristic feature of SARS <xref rid="bib38" ref-type="ref">38</xref>
. Curiously, lymphoid cells and lymphoid organs, including the spleen, do not harbour SARS‐CoV. The viral genome has rarely been demonstrated in macrophages of the lung <xref rid="bib39" ref-type="ref">39</xref>
. The absence of viral proteins and viral particles, however, suggests a passive role for macrophages as scavengers, rather than being the primary target <xref rid="bib25" ref-type="ref">25</xref>
, <xref rid="bib26" ref-type="ref">26</xref>
. While direct infection of the lymphoid system by SARS‐CoV seems unlikely, elevated levels of certain cytokines and chemokines are consistently observed in the serum of SARS patients <xref rid="bib40" ref-type="ref">40</xref>
, <xref rid="bib41" ref-type="ref">41</xref>
. In addition, the severity of SARS‐CoV infection may be related to the HLA haplotypes of different individuals <xref rid="bib42" ref-type="ref">42</xref>
, <xref rid="bib43" ref-type="ref">43</xref>
. It is likely that there are complex interactions between SARS‐CoV‐infected cells in various organs and the lymphoid network. Studies of expression and changes in cytokines, chemokines, and their corresponding receptors both at the tissue level and in individual cell types will be necessary to address these issues.</p>
<p>It is clear that we are only at the dawn of our understanding of the pathogenesis of SARS. Among all the cell types being investigated, pneumocytes and small intestinal enterocytes have consistently been shown to be the targets of SARS‐CoV infection. However, the cellular and tissue responses in these sites are different. The possibility of another cellular receptor(s) or co‐receptor(s) remains open. The interaction between SARS‐CoV and the immunological or lymphoid system needs to be defined. Further insights into the pathogenesis of SARS‐CoV may be gained from emerging new human cell culture models. As our understanding of the pathogenic mechanisms improves, a more rational approach to therapeutic and vaccine development can be designed in order to combat this new and fatal human disease.</p>
</body>
<back><ack id="sec1-ack-1"><title>Acknowledgements</title>
<p>We thank Dr Deborah MY Au of the Gene Company Limited (Hong Kong) for the kind gifts of anti‐peptide antibodies against various proteins of SARS‐CoV. The work described in this paper was partially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No CUHK4507/03M).</p>
</ack>
<ref-list><title>References</title>
<ref id="bib1"><label>1</label>
<mixed-citation publication-type="miscellaneous" id="cit1"><collab collab-type="authors">WHO</collab>
. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/sars/country/table2004_04_21/en/">http://www.who.int/csr/sars/country/table 2004_04_21/en/</ext-link>
[Accessed 28 April 2004].</mixed-citation>
</ref>
<ref id="bib2"><label>2</label>
<mixed-citation publication-type="miscellaneous" id="cit2"><collab collab-type="authors">WHO</collab>
. Severe acute respiratory syndrome (SARS). <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/archive/disease/severe_acute_respiratory_syndrome/en/">http://www.who.int/csr/don/archive/disease/severe_acute_respiratory_syndrome/en/</ext-link>
[Accessed 28 April 2004].</mixed-citation>
</ref>
<ref id="bib3"><label>3</label>
<mixed-citation publication-type="journal" id="cit3"><string-name><surname>Stadler</surname>
<given-names>K</given-names>
</string-name>
, <string-name><surname>Masignani</surname>
<given-names>V</given-names>
</string-name>
, <string-name><surname>Eickmann</surname>
<given-names>M</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>SARS—beginning to understand a new virus</article-title>
. <source xml:lang="en">Nature Rev Microbiol</source>
<year>2003</year>
; <volume>1</volume>
: <fpage>209</fpage>
–<lpage>218</lpage>
.<pub-id pub-id-type="pmid">15035025</pub-id>
</mixed-citation>
</ref>
<ref id="bib4"><label>4</label>
<mixed-citation publication-type="journal" id="cit4"><string-name><surname>Chinese</surname>
<given-names>SMEC</given-names>
</string-name>
. <article-title>Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China</article-title>
. <source xml:lang="en">Science</source>
<year>2004</year>
; <volume>303</volume>
: <fpage>1666</fpage>
–<lpage>1669</lpage>
.<pub-id pub-id-type="pmid">14752165</pub-id>
</mixed-citation>
</ref>
<ref id="bib5"><label>5</label>
<mixed-citation publication-type="journal" id="cit5"><string-name><surname>Chim</surname>
<given-names>SS</given-names>
</string-name>
, <string-name><surname>Tsui</surname>
<given-names>SK</given-names>
</string-name>
, <string-name><surname>Chan</surname>
<given-names>KC</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong</article-title>
. <source xml:lang="en">Lancet</source>
<year>2003</year>
; <volume>362</volume>
: <fpage>1807</fpage>
–<lpage>1808</lpage>
.<pub-id pub-id-type="pmid">14654320</pub-id>
</mixed-citation>
</ref>
<ref id="bib6"><label>6</label>
<mixed-citation publication-type="journal" id="cit6"><string-name><surname>Marra</surname>
<given-names>MA</given-names>
</string-name>
, <string-name><surname>Jones</surname>
<given-names>SJ</given-names>
</string-name>
, <string-name><surname>Astell</surname>
<given-names>CR</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>The Genome sequence of the SARS‐associated coronavirus</article-title>
. <source xml:lang="en">Science</source>
<year>2003</year>
; <volume>300</volume>
: <fpage>1399</fpage>
–<lpage>1404</lpage>
.<pub-id pub-id-type="pmid">12730501</pub-id>
</mixed-citation>
</ref>
<ref id="bib7"><label>7</label>
<mixed-citation publication-type="journal" id="cit7"><string-name><surname>Rota</surname>
<given-names>PA</given-names>
</string-name>
, <string-name><surname>Oberste</surname>
<given-names>MS</given-names>
</string-name>
, <string-name><surname>Monroe</surname>
<given-names>SS</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Characterization of a novel coronavirus associated with severe acute respiratory syndrome</article-title>
. <source xml:lang="en">Science</source>
<year>2003</year>
; <volume>300</volume>
: <fpage>1394</fpage>
–<lpage>1399</lpage>
.<pub-id pub-id-type="pmid">12730500</pub-id>
</mixed-citation>
</ref>
<ref id="bib8"><label>8</label>
<mixed-citation publication-type="journal" id="cit8"><string-name><surname>Lee</surname>
<given-names>N</given-names>
</string-name>
, <string-name><surname>Hui</surname>
<given-names>D</given-names>
</string-name>
, <string-name><surname>Wu</surname>
<given-names>A</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>A major outbreak of severe acute respiratory syndrome in Hong Kong</article-title>
. <source xml:lang="en">N Engl J Med</source>
<year>2003</year>
; <volume>348</volume>
: <fpage>1986</fpage>
–<lpage>1994</lpage>
.<pub-id pub-id-type="pmid">12682352</pub-id>
</mixed-citation>
</ref>
<ref id="bib9"><label>9</label>
<mixed-citation publication-type="journal" id="cit9"><string-name><surname>Wong</surname>
<given-names>GW</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>AM</given-names>
</string-name>
, <string-name><surname>Ng</surname>
<given-names>PC</given-names>
</string-name>
, <string-name><surname>Fok</surname>
<given-names>TF</given-names>
</string-name>
. <article-title>Severe acute respiratory syndrome in children</article-title>
. <source xml:lang="en">Pediatr Pulmonol</source>
<year>2003</year>
; <volume>36</volume>
: <fpage>261</fpage>
–<lpage>266</lpage>
.<pub-id pub-id-type="pmid">12950037</pub-id>
</mixed-citation>
</ref>
<ref id="bib10"><label>10</label>
<mixed-citation publication-type="journal" id="cit10"><string-name><surname>Tsang</surname>
<given-names>KW</given-names>
</string-name>
, <string-name><surname>Ho</surname>
<given-names>PL</given-names>
</string-name>
, <string-name><surname>Ooi</surname>
<given-names>GC</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>A cluster of cases of severe acute respiratory syndrome in Hong Kong</article-title>
. <source xml:lang="en">N Engl J Med</source>
<year>2003</year>
; <volume>348</volume>
: <fpage>1977</fpage>
–<lpage>1985</lpage>
.<pub-id pub-id-type="pmid">12671062</pub-id>
</mixed-citation>
</ref>
<ref id="bib11"><label>11</label>
<mixed-citation publication-type="journal" id="cit11"><string-name><surname>Zhan</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Chen</surname>
<given-names>W</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>C</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Digestive system manifestations in patients with severe acute respiratory syndrome</article-title>
. <source xml:lang="en">Chin Med J (Engl)</source>
<year>2003</year>
; <volume>116</volume>
: <fpage>1265</fpage>
–<lpage>1266</lpage>
.<pub-id pub-id-type="pmid">12935425</pub-id>
</mixed-citation>
</ref>
<ref id="bib12"><label>12</label>
<mixed-citation publication-type="journal" id="cit12"><string-name><surname>Leung</surname>
<given-names>WK</given-names>
</string-name>
, <string-name><surname>To</surname>
<given-names>KF</given-names>
</string-name>
, <string-name><surname>Chan</surname>
<given-names>PK</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Enteric involvement of severe acute respiratory syndrome‐associated coronavirus infection</article-title>
. <source xml:lang="en">Gastroenterology</source>
<year>2003</year>
; <volume>125</volume>
: <fpage>1011</fpage>
–<lpage>1017</lpage>
.<pub-id pub-id-type="pmid">14517783</pub-id>
</mixed-citation>
</ref>
<ref id="bib13"><label>13</label>
<mixed-citation publication-type="journal" id="cit13"><string-name><surname>Bisht</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Roberts</surname>
<given-names>A</given-names>
</string-name>
, <string-name><surname>Vogel</surname>
<given-names>L</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice</article-title>
. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2004</year>
; <volume>101</volume>
: <fpage>6641</fpage>
–<lpage>6646</lpage>
.<pub-id pub-id-type="pmid">15096611</pub-id>
</mixed-citation>
</ref>
<ref id="bib14"><label>14</label>
<mixed-citation publication-type="journal" id="cit14"><string-name><surname>Kim</surname>
<given-names>TW</given-names>
</string-name>
, <string-name><surname>Lee</surname>
<given-names>JH</given-names>
</string-name>
, <string-name><surname>Hung</surname>
<given-names>CF</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus</article-title>
. <source xml:lang="en">J Virol</source>
<year>2004</year>
; <volume>78</volume>
: <fpage>4638</fpage>
–<lpage>4645</lpage>
.<pub-id pub-id-type="pmid">15078946</pub-id>
</mixed-citation>
</ref>
<ref id="bib15"><label>15</label>
<mixed-citation publication-type="journal" id="cit15"><string-name><surname>Yang</surname>
<given-names>ZY</given-names>
</string-name>
, <string-name><surname>Kong</surname>
<given-names>WP</given-names>
</string-name>
, <string-name><surname>Huang</surname>
<given-names>Y</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice</article-title>
. <source xml:lang="en">Nature</source>
<year>2004</year>
; <volume>428</volume>
: <fpage>561</fpage>
–<lpage>564</lpage>
.<pub-id pub-id-type="pmid">15024391</pub-id>
</mixed-citation>
</ref>
<ref id="bib16"><label>16</label>
<mixed-citation publication-type="journal" id="cit16"><string-name><surname>Zhu</surname>
<given-names>MS</given-names>
</string-name>
, <string-name><surname>Pan</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Chen</surname>
<given-names>HQ</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Induction of SARS‐nucleoprotein‐specific immune response by use of DNA vaccine</article-title>
. <source xml:lang="en">Immunol Lett</source>
<year>2004</year>
; <volume>92</volume>
: <fpage>237</fpage>
–<lpage>243</lpage>
.<pub-id pub-id-type="pmid">15081618</pub-id>
</mixed-citation>
</ref>
<ref id="bib17"><label>17</label>
<mixed-citation publication-type="journal" id="cit17"><string-name><surname>Chong</surname>
<given-names>PY</given-names>
</string-name>
, <string-name><surname>Chui</surname>
<given-names>P</given-names>
</string-name>
, <string-name><surname>Ling</surname>
<given-names>AE</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis</article-title>
. <source xml:lang="en">Arch Pathol Lab Med</source>
<year>2004</year>
; <volume>128</volume>
: <fpage>195</fpage>
–<lpage>204</lpage>
.<pub-id pub-id-type="pmid">14736283</pub-id>
</mixed-citation>
</ref>
<ref id="bib18"><label>18</label>
<mixed-citation publication-type="journal" id="cit18"><string-name><surname>Ding</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Wang</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Shen</surname>
<given-names>H</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>The clinical pathology of severe acute respiratory syndrome (SARS): a report from China</article-title>
. <source xml:lang="en">J Pathol</source>
<year>2003</year>
; <volume>200</volume>
: <fpage>282</fpage>
–<lpage>289</lpage>
.<pub-id pub-id-type="pmid">12845623</pub-id>
</mixed-citation>
</ref>
<ref id="bib19"><label>19</label>
<mixed-citation publication-type="journal" id="cit19"><string-name><surname>Franks</surname>
<given-names>TJ</given-names>
</string-name>
, <string-name><surname>Chong</surname>
<given-names>PY</given-names>
</string-name>
, <string-name><surname>Chui</surname>
<given-names>P</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore</article-title>
. <source xml:lang="en">Hum Pathol</source>
<year>2003</year>
; <volume>34</volume>
: <fpage>743</fpage>
–<lpage>748</lpage>
.<pub-id pub-id-type="pmid">14506633</pub-id>
</mixed-citation>
</ref>
<ref id="bib20"><label>20</label>
<mixed-citation publication-type="journal" id="cit20"><string-name><surname>Lang</surname>
<given-names>Z</given-names>
</string-name>
, <string-name><surname>Zhang</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Zhang</surname>
<given-names>S</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Pathological study on severe acute respiratory syndrome</article-title>
. <source xml:lang="en">Chin Med J (Engl)</source>
<year>2003</year>
; <volume>116</volume>
: <fpage>976</fpage>
–<lpage>980</lpage>
.<pub-id pub-id-type="pmid">12890365</pub-id>
</mixed-citation>
</ref>
<ref id="bib21"><label>21</label>
<mixed-citation publication-type="journal" id="cit21"><string-name><surname>Nicholls</surname>
<given-names>JM</given-names>
</string-name>
, <string-name><surname>Poon</surname>
<given-names>LL</given-names>
</string-name>
, <string-name><surname>Lee</surname>
<given-names>KC</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Lung pathology of fatal severe acute respiratory syndrome</article-title>
. <source xml:lang="en">Lancet</source>
<year>2003</year>
; <volume>361</volume>
: <fpage>1773</fpage>
–<lpage>1778</lpage>
.<pub-id pub-id-type="pmid">12781536</pub-id>
</mixed-citation>
</ref>
<ref id="bib22"><label>22</label>
<mixed-citation publication-type="journal" id="cit22"><string-name><surname>Tse</surname>
<given-names>GM</given-names>
</string-name>
, <string-name><surname>To</surname>
<given-names>KF</given-names>
</string-name>
, <string-name><surname>Chan</surname>
<given-names>PK</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)</article-title>
. <source xml:lang="en">J Clin Pathol</source>
<year>2004</year>
; <volume>57</volume>
: <fpage>260</fpage>
–<lpage>265</lpage>
.<pub-id pub-id-type="pmid">14990596</pub-id>
</mixed-citation>
</ref>
<ref id="bib23"><label>23</label>
<mixed-citation publication-type="journal" id="cit23"><string-name><surname>Chow</surname>
<given-names>KC</given-names>
</string-name>
, <string-name><surname>Hsiao</surname>
<given-names>CH</given-names>
</string-name>
, <string-name><surname>Lin</surname>
<given-names>TY</given-names>
</string-name>
, <string-name><surname>Chen</surname>
<given-names>CL</given-names>
</string-name>
, <string-name><surname>Chiou</surname>
<given-names>SH</given-names>
</string-name>
. <article-title>Detection of severe acute respiratory syndrome‐associated coronavirus in pneumocytes of the lung</article-title>
. <source xml:lang="en">Am J Clin Pathol</source>
<year>2004</year>
; <volume>121</volume>
: <fpage>574</fpage>
–<lpage>580</lpage>
.<pub-id pub-id-type="pmid">15080310</pub-id>
</mixed-citation>
</ref>
<ref id="bib24"><label>24</label>
<mixed-citation publication-type="journal" id="cit24"><string-name><surname>Nakajima</surname>
<given-names>N</given-names>
</string-name>
, <string-name><surname>Asahi‐Ozaki</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Nagata</surname>
<given-names>N</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>SARS coronavirus‐infected cells in lung detected by new <italic>in situ</italic>
hybridization technique</article-title>
. <source xml:lang="en">Jpn J Infect Dis</source>
<year>2003</year>
; <volume>56</volume>
: <fpage>139</fpage>
–<lpage>141</lpage>
.<pub-id pub-id-type="pmid">12944688</pub-id>
</mixed-citation>
</ref>
<ref id="bib25"><label>25</label>
<mixed-citation publication-type="journal" id="cit25"><string-name><surname>To</surname>
<given-names>KF</given-names>
</string-name>
, <string-name><surname>Tong</surname>
<given-names>JH</given-names>
</string-name>
, <string-name><surname>Chan</surname>
<given-names>PK</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an <italic>in‐situ</italic>
hybridization study of fatal cases</article-title>
. <source xml:lang="en">J Pathol</source>
<year>2004</year>
; <volume>202</volume>
: <fpage>157</fpage>
–<lpage>163</lpage>
.<pub-id pub-id-type="pmid">14743497</pub-id>
</mixed-citation>
</ref>
<ref id="bib26"><label>26</label>
<mixed-citation publication-type="journal" id="cit26"><string-name><surname>Ding</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>He</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways</article-title>
. <source xml:lang="en">J Pathol</source>
<year>2004</year>
; <volume>203</volume>
: <fpage>622</fpage>
–<lpage>630</lpage>
.<pub-id pub-id-type="pmid">15141376</pub-id>
</mixed-citation>
</ref>
<ref id="bib27"><label>27</label>
<mixed-citation publication-type="journal" id="cit27"><string-name><surname>Choi</surname>
<given-names>KW</given-names>
</string-name>
, <string-name><surname>Chau</surname>
<given-names>TN</given-names>
</string-name>
, <string-name><surname>Tsang</surname>
<given-names>O</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong</article-title>
. <source xml:lang="en">Ann Intern Med</source>
<year>2003</year>
; <volume>139</volume>
: <fpage>715</fpage>
–<lpage>723</lpage>
.<pub-id pub-id-type="pmid">14597455</pub-id>
</mixed-citation>
</ref>
<ref id="bib28"><label>28</label>
<mixed-citation publication-type="journal" id="cit28"><string-name><surname>Chan</surname>
<given-names>KH</given-names>
</string-name>
, <string-name><surname>Poon</surname>
<given-names>LL</given-names>
</string-name>
, <string-name><surname>Cheng</surname>
<given-names>VC</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Detection of SARS coronavirus in patients with suspected SARS</article-title>
. <source xml:lang="en">Emerg Infect Dis</source>
<year>2004</year>
; <volume>10</volume>
: <fpage>294</fpage>
–<lpage>299</lpage>
.<pub-id pub-id-type="pmid">15030700</pub-id>
</mixed-citation>
</ref>
<ref id="bib29"><label>29</label>
<mixed-citation publication-type="journal" id="cit29"><collab collab-type="authors">WHO</collab>
. <article-title>Inadequate plumbing systems probably contributed to SARS transmission</article-title>
. <source xml:lang="en">Wkly Epidemiol Rec</source>
<year>2003</year>
; <volume>78</volume>
: <fpage>371</fpage>
–<lpage>372</lpage>
.<pub-id pub-id-type="pmid">14587210</pub-id>
</mixed-citation>
</ref>
<ref id="bib30"><label>30</label>
<mixed-citation publication-type="journal" id="cit30"><string-name><surname>Chau</surname>
<given-names>TN</given-names>
</string-name>
, <string-name><surname>Lee</surname>
<given-names>KC</given-names>
</string-name>
, <string-name><surname>Yao</surname>
<given-names>H</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>SARS‐associated viral hepatitis caused by a novel coronavirus: report of three cases</article-title>
. <source xml:lang="en">Hepatology</source>
<year>2004</year>
; <volume>39</volume>
: <fpage>302</fpage>
–<lpage>310</lpage>
.<pub-id pub-id-type="pmid">14767982</pub-id>
</mixed-citation>
</ref>
<ref id="bib31"><label>31</label>
<mixed-citation publication-type="journal" id="cit31"><string-name><surname>Burrell</surname>
<given-names>LM</given-names>
</string-name>
, <string-name><surname>Johnston</surname>
<given-names>CI</given-names>
</string-name>
, <string-name><surname>Tikellis</surname>
<given-names>C</given-names>
</string-name>
, <string-name><surname>Cooper</surname>
<given-names>ME</given-names>
</string-name>
. <article-title>ACE2, a new regulator of the renin–angiotensin system</article-title>
. <source xml:lang="en">Trends Endocrinol Metabol</source>
<year>2004</year>
; <volume>15</volume>
: <fpage>167</fpage>
–<lpage>169</lpage>
.</mixed-citation>
</ref>
<ref id="bib32"><label>32</label>
<mixed-citation publication-type="journal" id="cit32"><string-name><surname>Li</surname>
<given-names>W</given-names>
</string-name>
, <string-name><surname>Moore</surname>
<given-names>MJ</given-names>
</string-name>
, <string-name><surname>Vasilieva</surname>
<given-names>N</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Angiotensin‐converting enzyme 2 is a functional receptor for the SARS coronavirus</article-title>
. <source xml:lang="en">Nature</source>
<year>2003</year>
; <volume>426</volume>
: <fpage>450</fpage>
–<lpage>454</lpage>
.<pub-id pub-id-type="pmid">14647384</pub-id>
</mixed-citation>
</ref>
<ref id="bib33"><label>33</label>
<mixed-citation publication-type="journal" id="cit33"><string-name><surname>Wang</surname>
<given-names>P</given-names>
</string-name>
, <string-name><surname>Chen</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Zheng</surname>
<given-names>A</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Expression cloning of functional receptor used by SARS coronavirus</article-title>
. <source xml:lang="en">Biochem Biophys Res Commun</source>
<year>2004</year>
; <volume>315</volume>
: <fpage>439</fpage>
–<lpage>444</lpage>
.<pub-id pub-id-type="pmid">14766227</pub-id>
</mixed-citation>
</ref>
<ref id="bib34"><label>34</label>
<mixed-citation publication-type="journal" id="cit34"><string-name><surname>Wong</surname>
<given-names>SK</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>W</given-names>
</string-name>
, <string-name><surname>Moore</surname>
<given-names>MJ</given-names>
</string-name>
, <string-name><surname>Choe</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Farzan</surname>
<given-names>M</given-names>
</string-name>
. <article-title>A 193‐amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin‐converting enzyme 2</article-title>
. <source xml:lang="en">J Biol Chem</source>
<year>2004</year>
; <volume>279</volume>
: <fpage>3197</fpage>
–<lpage>3201</lpage>
.<pub-id pub-id-type="pmid">14670965</pub-id>
</mixed-citation>
</ref>
<ref id="bib35"><label>35</label>
<mixed-citation publication-type="journal" id="cit35"><string-name><surname>Xiao</surname>
<given-names>X</given-names>
</string-name>
, <string-name><surname>Chakraborti</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Dimitrov</surname>
<given-names>AS</given-names>
</string-name>
, <string-name><surname>Gramatikoff</surname>
<given-names>K</given-names>
</string-name>
, <string-name><surname>Dimitrov</surname>
<given-names>DS</given-names>
</string-name>
. <article-title>The SARS‐CoV S glycoprotein: expression and functional characterization</article-title>
. <source xml:lang="en">Biochem Biophys Res Commun</source>
<year>2003</year>
; <volume>312</volume>
: <fpage>1159</fpage>
–<lpage>1164</lpage>
.<pub-id pub-id-type="pmid">14651994</pub-id>
</mixed-citation>
</ref>
<ref id="bib36"><label>36</label>
<mixed-citation publication-type="journal" id="cit36"><string-name><surname>Hamming</surname>
<given-names>I</given-names>
</string-name>
, <string-name><surname>Timens</surname>
<given-names>W</given-names>
</string-name>
, <string-name><surname>Bulithuis</surname>
<given-names>MLC</given-names>
</string-name>
, <string-name><surname>Lely</surname>
<given-names>AT</given-names>
</string-name>
, <string-name><surname>Navis</surname>
<given-names>GJ</given-names>
</string-name>
, <string-name><surname>van Goor</surname>
<given-names>H</given-names>
</string-name>
. <article-title>Tissue distribution of ACE2 proteins, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis</article-title>
. <source xml:lang="en">J Pathol</source>
<year>2004</year>
; <volume>203</volume>
: <fpage>631</fpage>
–<lpage>637</lpage>
.<pub-id pub-id-type="pmid">15141377</pub-id>
</mixed-citation>
</ref>
<ref id="bib37"><label>37</label>
<mixed-citation publication-type="journal" id="cit37"><string-name><surname>Chan</surname>
<given-names>P</given-names>
</string-name>
, <string-name><surname>To</surname>
<given-names>KF</given-names>
</string-name>
, <string-name><surname>Lo</surname>
<given-names>AW</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Persistent infection of SARS coronavirus in colonic cells <italic>in‐vitro</italic>
</article-title>
. <source xml:lang="en">J Med Virol</source>
(in press).</mixed-citation>
</ref>
<ref id="bib38"><label>38</label>
<mixed-citation publication-type="journal" id="cit38"><string-name><surname>Wong</surname>
<given-names>RS</given-names>
</string-name>
, <string-name><surname>Wu</surname>
<given-names>A</given-names>
</string-name>
, <string-name><surname>To</surname>
<given-names>KF</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis</article-title>
. <source xml:lang="en">Br Med J</source>
<year>2003</year>
; <volume>326</volume>
: <fpage>1358</fpage>
–<lpage>1362</lpage>
.<pub-id pub-id-type="pmid">12816821</pub-id>
</mixed-citation>
</ref>
<ref id="bib39"><label>39</label>
<mixed-citation publication-type="journal" id="cit39"><string-name><surname>Chen</surname>
<given-names>P</given-names>
</string-name>
, <string-name><surname>Hsiao</surname>
<given-names>CH</given-names>
</string-name>
. <article-title>Presence of SARS‐coronavirus in macrophages</article-title>
. <source xml:lang="en">J Pathol</source>
<year>2004</year>
; <volume>203</volume>
: <fpage>729</fpage>
–<lpage>730</lpage>
.<pub-id pub-id-type="pmid">15141389</pub-id>
</mixed-citation>
</ref>
<ref id="bib40"><label>40</label>
<mixed-citation publication-type="journal" id="cit40"><string-name><surname>Ng</surname>
<given-names>PC</given-names>
</string-name>
, <string-name><surname>Lam</surname>
<given-names>CW</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>AM</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Inflammatory cytokine profile in children with severe acute respiratory syndrome</article-title>
. <source xml:lang="en">Pediatrics</source>
<year>2004</year>
; <volume>113</volume>
: <fpage>e7</fpage>
–<lpage>e14</lpage>
.<pub-id pub-id-type="pmid">14702488</pub-id>
</mixed-citation>
</ref>
<ref id="bib41"><label>41</label>
<mixed-citation publication-type="journal" id="cit41"><string-name><surname>Wong</surname>
<given-names>CK</given-names>
</string-name>
, <string-name><surname>Lam</surname>
<given-names>CW</given-names>
</string-name>
, <string-name><surname>Wu</surname>
<given-names>AK</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome</article-title>
. <source xml:lang="en">Clin Exp Immunol</source>
<year>2004</year>
; <volume>136</volume>
: <fpage>95</fpage>
–<lpage>103</lpage>
.<pub-id pub-id-type="pmid">15030519</pub-id>
</mixed-citation>
</ref>
<ref id="bib42"><label>42</label>
<mixed-citation publication-type="journal" id="cit42"><string-name><surname>Lin</surname>
<given-names>M</given-names>
</string-name>
, <string-name><surname>Tseng</surname>
<given-names>HK</given-names>
</string-name>
, <string-name><surname>Trejaut</surname>
<given-names>JA</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Association of HLA class I with severe acute respiratory syndrome coronavirus infection</article-title>
. <source xml:lang="en">BMC Med Genet</source>
<year>2003</year>
; <volume>4</volume>
: <fpage>9</fpage>
.<pub-id pub-id-type="pmid">12969506</pub-id>
</mixed-citation>
</ref>
<ref id="bib43"><label>43</label>
<mixed-citation publication-type="journal" id="cit43"><string-name><surname>Ng</surname>
<given-names>MH</given-names>
</string-name>
, <string-name><surname>Lau</surname>
<given-names>KM</given-names>
</string-name>
, <string-name><surname>Lau</surname>
<given-names>L</given-names>
</string-name>
, <italic>et al.</italic>
<article-title>Association of HLA class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance of severe acute respiratory syndrome (SARS)</article-title>
. <source xml:lang="en">J Infect Dis</source>
(in press).</mixed-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000791 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000791 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:7167902 |texte= Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2) }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:NONE" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |